NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

27 August 2022 (17:15 - 18:00)
Organised by:
Congress Presentation Part of: Biomarkers for heart failure 1 Biomarkers ESC Professional Premium Access ESC Congress 2022